ProCE Banner Activity

Clinical Trial Evidence of the Use of Anti-EZH1/2 Therapies in PTCL and Managing Adverse Events

Slideset Download
Download these slides from a live expert-led satellite symposium reviewing the clinical trial efficacy and safety of Anti-EZH1 and EZH2 therapies in PTCL.

Released: June 03, 2022

Expiration: June 02, 2023

No longer available for credit.

Share

Faculty

Steven M. Horwitz

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York